NEW YORK ( TheStreet) -- ArthroCare Corporation (Nasdaq: ARTC) hit a new 52-week low Monday as it is currently trading at $26.20, below its previous 52-week low of $26.27 with 125,343 shares traded as of 3:09 p.m. ET. Average volume has been 150,300 shares over the past 30 days. ArthroCare has a market cap of $754.4 million and is part of the health care sector and health services industry. Shares are down 14% year to date as of the close of trading on Friday. ArthroCare Corporation, a medical device company, develops, manufactures, and markets surgical products primarily based on its minimally invasive patented Coblation technology. The company has a P/E ratio of 28, above the average health services industry P/E ratio of 27.7 and above the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates ArthroCare as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, unimpressive growth in net income and disappointing return on equity. You can view the full ArthroCare Ratings Report. See all 52-week low stocks or get investment ideas from our investment research center.